Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-25-316569·Foundation Fighting Blindness Retinal Degeneration Fund
Schedule 13D ownership disclosure
Opus Genetics, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 67577R102
Event date: 2025-12-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Foundation Fighting Blindness Retinal Degeneration FundReported CIK 0002042266
Shares: 5,492,171 · Class: 8.0%
- Foundation Fighting Blindness, Inc.Reported CIK 0002042532
Shares: 5,492,171 · Class: 8.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-316569
- Form type
- SCHEDULE 13D/A
- Filer
- Foundation Fighting Blindness Retinal Degeneration Fund
- CIK
- CIK 2042266
- Filed
- Dec 11, 2025
- Reporting period
- Dec 09, 2025
- Description
- Schedule 13D beneficial ownership